Morepen Laboratories has executed a Business Transfer Agreement (BTA) with its subsidiary -- Morepen Medtech for the hiving-off of Medical Devices Business on a 'slump sale’ as a going concern basis.
Earlier, the company’s board had approved the same in its meeting held on January 14, 2025. The completion of the slump sale of the Medical Devices Business was expected to be completed on or before September 30, 2025, subject to receipt of requisite regulatory and other approvals and fulfilment of customary conditions precedent and in accordance with the provisions of the BTA.
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products.
